Empirico Inc.
AI-powered clinical decision support system using retrieval augmented generation for diagnosis and treatment recommendations
- Sector
- Digital health
- Headquarters
- SAN DIEGO, CA
- Founded
- 2017
- Latest Form D
- $45.2M, Mar 2023
- Total capital
- $74.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $74.8M
- 3 Form D · last Mar 2023
- 43 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 10
- 30 pending · first 2021
- Rank in peer group#6 of 197
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$45.2M
- Private capital raisedForm D · SEC · 2nd filing$17M
- Private capital raisedForm D · SEC · 1st filing$12.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 197 peers
Line = medianDigital health · Software
- Granted patents#6 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Brian CajesExecutive OfficerNamed in SEC Form D filings
- Dennis LangerDirectorNamed in SEC Form D filings
- John HamerDirectorNamed in SEC Form D filings
- Kolluri SwaroopDirectorNamed in SEC Form D filings
- Omri GottesmanExecutive Officer, DirectorNamed in SEC Form D filings
- Shannon BruseExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 10 granted of 40- PendingTreatment Of MTRES1 Related Diseases And DisordersUSPTOApplication 19132713
- GrantedOligonucleotides For Treatment Of Angiopoietin Like 4 (ANGPTL4) Related DiseasesUSPTOUS 12,674,165
- PendingProcess To Inhibit Or Eliminate Eosinophilic Diseases Of The Airway And Related ConditionsUSPTOApplication 19048749
Show all 40 patent records
- Treatment Of MTRES1 Related Diseases And DisordersJul 9, 2026 · Application 19132713Pending
- Oligonucleotides For Treatment Of Angiopoietin Like 4 (ANGPTL4) Related DiseasesJul 7, 2026 · US 12,674,165Granted
- Process To Inhibit Or Eliminate Eosinophilic Diseases Of The Airway And Related ConditionsJun 25, 2026 · Application 19048749Pending
- Treatment Of Thymic Stromal Lymphopoietin (tslp) Related Diseases By Inhibition Of Long-form Tslp TranscriptsApr 2, 2026 · Application 19212537Pending
- Treatment Of MST1 Related Diseases And DisordersFeb 26, 2026 · Application 19078172Pending
- Treatment Of MS4A4E Related Diseases And DisordersDec 4, 2025 · Application 18873703Pending
- Treatment Of SOS2 Related Diseases And DisordersOct 30, 2025 · Application 18866499Pending
- Small Molecule Treatment Of MTRES1 Related Diseases And DisordersOct 23, 2025 · Application 19122140Pending
- Treatment Of MST1 Related Diseases And DisordersOct 9, 2025 · Application 19169752Pending
- Modified OligonucleotidesAug 7, 2025 · Application 19045490Pending
- Treatment Of Angiopoietin Like 7 (ANGPTL7) Related DiseasesAug 5, 2025 · US 12,378,556Granted
- Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related ConditionsJul 17, 2025 · Application 18819874Pending
- Compositions And Methods For The Treatment Of Angiopoietin Like 7 (ANGPTL7) Related DiseasesJun 19, 2025 · Application 18848846Pending
- Treatment Of Hgfac Related Diseases And DisordersJun 19, 2025 · Application 18845818Pending
- Galnac Compositions For Improving Sirna BioavailabilityJun 19, 2025 · Application 19059140Pending
- Treatment Of MST1 Related Diseases And DisordersMay 27, 2025 · US 12,312,586Granted
- Modified OligonucleotidesMar 25, 2025 · US 12,258,563Granted
- Galnac Compositions For Improving Sirna BioavailabilityMar 25, 2025 · US 12,258,564Granted
- Prodrugs Of ALOX-15 Inhibitors And Methods Of Using The SameMar 20, 2025 · Application 18961204Pending
- Treatment Of Fgg Related Diseases And DisordersFeb 6, 2025 · Application 18714537Pending
- Treatment Of MST1 Related Diseases And DisordersNov 28, 2024 · Application 18795002Pending
- Treatment Of MST1R Related Diseases And DisordersNov 28, 2024 · Application 18567669Pending
- Treatment Of DKK2 Related Diseases And DisordersAug 29, 2024 · Application 18569113Pending
- Treatment Of MTRES1 Related Diseases And DisordersAug 29, 2024 · Application 18568758Pending
- Treatment Of MST1 Related Diseases And DisordersAug 29, 2024 · Application 18625829Pending
- Treatment Of PLIN1 Related Diseases And DisordersAug 29, 2024 · Application 18568170Pending
- Treatment Of ANGPTL4 Related DiseasesAug 22, 2024 · Application 18567011Pending
- Treatment Of MST1 Related Diseases And DisordersMay 30, 2024 · Application 18567342Pending
- Galnac Compositions For Improving Sirna BioavailabilityJan 23, 2024 · US 11,879,125Granted
- Galnac Compositions For Improving Sirna BioavailabilityJan 18, 2024 · Application 18037960Pending
- Treatment Of SOS2 Related Diseases And DisordersDec 21, 2023 · Application 18037959Pending
- Compositions And Methods For The Treatment Of Angiopoietin Like 7 (ANGPTL7) Related DiseasesNov 9, 2023 · Application 18028992Pending
- Prodrugs Of ALOX-15 Inhibitors And Methods Of Using The SameAug 10, 2023 · Application 18302713Pending
- Prodrugs Of ALOX-15 Inhibitors And Methods Of Using The SameJun 6, 2023 · US 11,666,588Granted
- Treatment Of Thymic Stromal Lymphopoietin (tslp) Related Diseases By Inhibition Of Long-form Tslp TranscriptsMar 9, 2023 · Application 17821693Pending
- Treatment Of Thymic Stromal Lymphopoietin (tslp) Related Diseases By Inhibition Of Long-form Tslp TranscriptsSep 27, 2022 · US 11,452,738Granted
- Oligonucleotides For Treatment Of Angiopoietin Like 4 (ANGPTL4) Related DiseasesJul 5, 2022 · US 11,377,658Granted
- Process To Inhibit Or Eliminate Eosinophilic Diseases Of The Airway And Related ConditionsFeb 24, 2022 · Application 17298896Pending
- Process To Inhibit Or Eliminate Eosinophilic Diseases Of The Airway And Related ConditionsNov 25, 2021 · Application 16967926Pending
- Prodrugs Of ALOX-15 Inhibitors And Methods Of Using The SameSep 14, 2021 · US 11,116,778Granted
Related companies, and why
- Rollgevity, Inc.Similar federal contract value in Digital health · null in contracts
- CodaMetrix Inc.Similar federal contract value in Digital health · null in contracts
- Clinic Chat LLCSimilar federal contract value in Digital health · null in contracts
- AGILEMD, INC.Similar federal contract value in Digital health · null in contracts
- Clinacuity, IncSimilar federal contract value in Digital health · null in contracts
- Brooklyn Pointe, LLCSimilar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .